Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 4 1

Status

Recruiting 3Completed 2Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 14Gastrointestinal 13Gynecologic 7Thoracic 5Head & Neck 5Dermatologic 5Tumor-Agnostic 3CNS 3Sarcoma 2Genitourinary 2Other solid neoplasm 1

Conditions

Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Osteosarcoma 1Neoplasms 1Bone Neoplasms 1

Interventions

Radiotherapy 144Doxorubicin 112Temozolomide 110Cyclophosphamide 110Filgrastim 79Ifosfamide 70Imatinib Mesylate 69Etoposide 69Bevacizumab 55Vincristine 51Gemcitabine 50Peripheral Blood Stem Cell Transplantation 47Irinotecan 43Methotrexate 39Cisplatin 36Carboplatin 36Radiation 35fludarabine phosphate 34Busulfan 34pazopanib 32Sirolimus 30Melphalan 30Trabectedin 29Docetaxel 27Chemotherapy, Adjuvant 27Cyclosporine 25Carmustine 25sargramostim 24Surgical Procedures, Operative 23Sunitinib 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Indocyanine Green × Sarcoma × Clear all
NCT05075889 2024-05-14

Utility of ICG in Benign Bone Tumors

Dartmouth-Hitchcock Medical Center

Phase EARLY_PHASE1 Completed
2 enrolled
Sarcoma

Bone Neoplasms

NCT04854018 2023-08-14

Indo-cyanine Green (ICG) in Paediatric Oncology MIS

Birmingham Women's and Children's NHS Foundation Trust

Phase 4 Completed
20 enrolled
Sarcoma

Neoplasms, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡